Eli Lilly to Cut Price of Insulin

March 1, 2023 by Dan McCue
Eli Lilly to Cut Price of Insulin
FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. (AP Photo/Darron Cummings, File)

INDIANAPOLIS, Ind. — Eli Lilly and Company said Wednesday that it is reducing the price of its most commonly prescribed insulins by as much as 70% and expanding a program that caps the monthly out-of-pocket cost for patients at $35.

The cost of insulin has been a flashpoint on Capitol Hill and the White House where it has entered into nearly every discussion of the high cost of health care in the U.S.

In a tweet, President Joe Biden called Lilly’s announcement “huge news.”

“Last year, we capped insulin prices for seniors on Medicare, but there was more work to do,” the president said. “I called on Congress — and manufacturers — to lower insulin prices for everyone else.

“Today, Eli Lilly is heeding my call. Others should follow,” Biden said.

It is estimated that about 30 million Americans rely on insulin as they try to manage diabetes. 

However, the drug, which is typically taken daily, has grown increasingly expensive, causing many diabetes patients to either ration their medicine or stop taking it completely.

In a press release issued Wednesday morning, Lilly said it was taking its actions “to help Americans who may have difficulty navigating a complex health care system that may keep them from getting affordable insulin.”

“While the current health care system provides access to insulin for most people with diabetes, it still does not provide affordable insulin for everyone and that needs to change,” said David Ricks, Lilly’s chair and CEO, in a written statement. 

“The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes,” Ricks continued. “Because these price cuts will take time for the insurance and pharmacy system to implement, we are taking the additional step to immediately cap out-of-pocket costs for patients who use Lilly insulin and are not covered by the recent Medicare Part D cap.”

As of May 1, 2023, the list price of Lilly’s non-branded insulin, Insulin Lispro Injection 100 units/mL, will drop to $25 a vial. 

At the time, it will become the lowest list-priced mealtime insulin available, and less than the price of a Humalog® vial in 1999.

That will be followed, by the end of the year, by a 70% reduction of the list price of Humalog® (insulin lispro injection) 100 units/mL1 and Humulin® (insulin human) injection 100 units/mL2.

Humalog® is Lilly’s most commonly prescribed insulin.

In addition, on April 1, the company will launch its new Rezvoglar® (insulin glargine-aglr) injection, a basal insulin that is biosimilar to, and interchangeable with, Lantus® (insulin glargine) injection, for $92 per five pack of KwikPens® — a 78% discount to Lantus.

In addition to reducing the list price of its insulins, Lilly said it will cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance.

The company also said people who don’t have insurance can continue to go to InsulinAffordability.com and immediately download the Lilly Insulin Value Program savings card to receive Lilly insulins for $35 per month.

Lilly said it will launch a nationwide public awareness campaign “in coming weeks,” to help ensure insulin users understand how to take advantage of the cost reductions announced Wednesday.

Ricks said while Lilly believes it is “driving for change in repricing older insulins,” the reality is seven out of 10 Americans who use insulin don’t use its products.

“We are calling on policymakers, employers and others to join us in making insulin more affordable,” he said. 

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • Eli Lilly
  • insulin
  • In The News

    Health

    Voting

    Health

    Biden Announcing New Rule to Protect Consumers Who Purchase Short-Term Health Insurance Plans

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A... Read More

    President Joe Biden on Thursday announced new steps to protect consumers who buy short-term health insurance plans that critics say amount to junk. A new rule finalized by the Democratic president's administration will limit these plans to just three months. And the plans can only be renewed for a maximum... Read More

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    News From The Well
    scroll top